ReviewJournal of translational medicine2024

Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis.

Jie Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.